Catalyst
Slingshot members are tracking this event:
Extended pharmacology: anti-IL5 mAb – Phase III expected to start in 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GSK | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 19, 2018
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03470311
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Anti-il5 Mab, Phase 3
